Sodium-glucose transporter 2 inhibitors in type 2 diabetes mellitus: navigating between Scylla and Charybdis (2014)
- Authors:
- USP affiliated authors: MACHADO, UBIRATAN FABRES - ICB ; GIANNELLA, MARIA LUCIA CARDILLO CORREA - FM
- Unidades: ICB; FM
- DOI: 10.1517/14728214.2014.875530
- Subjects: FISIOLOGIA; GLICOSE; DIABETES MELLITUS; HEMOGLOBINAS; MEDICAMENTO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Expert Opinion on Emerging Drugs
- ISSN: 1744-7623
- Volume/Número/Paginação/Ano: v. 19, n. 1, p. 5-9, 2014
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
MACHADO, Ubiratan Fabres e GIANNELLA, Maria Lúcia Cardillo Côrrea. Sodium-glucose transporter 2 inhibitors in type 2 diabetes mellitus: navigating between Scylla and Charybdis. Expert Opinion on Emerging Drugs, v. 19, n. 1, p. 5-9, 2014Tradução . . Disponível em: https://doi.org/10.1517/14728214.2014.875530. Acesso em: 03 abr. 2026. -
APA
Machado, U. F., & Giannella, M. L. C. C. (2014). Sodium-glucose transporter 2 inhibitors in type 2 diabetes mellitus: navigating between Scylla and Charybdis. Expert Opinion on Emerging Drugs, 19( 1), 5-9. doi:10.1517/14728214.2014.875530 -
NLM
Machado UF, Giannella MLCC. Sodium-glucose transporter 2 inhibitors in type 2 diabetes mellitus: navigating between Scylla and Charybdis [Internet]. Expert Opinion on Emerging Drugs. 2014 ; 19( 1): 5-9.[citado 2026 abr. 03 ] Available from: https://doi.org/10.1517/14728214.2014.875530 -
Vancouver
Machado UF, Giannella MLCC. Sodium-glucose transporter 2 inhibitors in type 2 diabetes mellitus: navigating between Scylla and Charybdis [Internet]. Expert Opinion on Emerging Drugs. 2014 ; 19( 1): 5-9.[citado 2026 abr. 03 ] Available from: https://doi.org/10.1517/14728214.2014.875530 - SLC2A4gene: a promising target for pharmacogenomics of insulin resistance [Editorial]
- Oleic and linoleic fatty acids downregulate Slc2a4/GLUT4 expression via NFKB and SREBP1 in skeletal muscle cells
- Expression analysis of proto-oncogene ret in patients with primary hyperparathyroidism: comparison between hyperplasia, adenoma and carcinoma
- Continuous glucose monitoring system: dawn period calibration does not change accuracy
- Sex-specific associations of variants in regulatory regions of NADPH oxidase-2 (CYBB) and glutathione peroxidase 4 (GPX4) genes with kidney disease in type 1 diabetes
- Validation of serum MicroRNAs-19a,-24, and-29a as potential markers to differentiate pancreatic cancer-associated diabetes From type 2 diabetes mellitus. [Carta]
- Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice
- Association between tumor GHSR-IA mRNA expression and in vivo response to GHRP-6 in patients with ACTH-dependent Cushing`s syndrome
- Visceral adiposity syndrome
- Polymorphisms in the gene encoding glucose transporter Glut-1 (SLC2A1) and renal disease in type 1 diabetic patients
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
